Zhu et al. recently found that the knockdown of YTHDC1 increases the expression of VPS25 and promotes the proliferation of glioma cells, and therefore the METTL3-m6A-YTHDC1 axis could also be impaired in GBM [81]. The gene discussed is YTHDC1; the disease is central nervous system cancer.